We focus on amyloid-beta (Aβ) and tau for AD, α-synuclein (α-syn) for PD, fused in sarcoma (FUS) and the TAR DNA-binding protein 43 (TDP-43) for ALS and FTD. This evidence concerns the gene FUS and Parkinson disease.